82 related articles for article (PubMed ID: 6937701)
21. Glutamine and the regulation of DNA replication and cell multiplication in fibroblasts.
Zetterberg A; Engström W
J Cell Physiol; 1981 Sep; 108(3):365-73. PubMed ID: 7287825
[TBL] [Abstract][Full Text] [Related]
22. Comparison of metabolic flux distributions for MDCK cell growth in glutamine- and pyruvate-containing media.
Sidorenko Y; Wahl A; Dauner M; Genzel Y; Reichl U
Biotechnol Prog; 2008; 24(2):311-20. PubMed ID: 18215054
[TBL] [Abstract][Full Text] [Related]
23. The effect of vincristine on methotrexate uptake and inhibition of DNA synthesis by human lymphoblastoid cells.
Warren RD; Nichols AP; Bender RA
Cancer Res; 1977 Sep; 37(9):2993-7. PubMed ID: 884658
[No Abstract] [Full Text] [Related]
24. Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase.
Jackman AL; Kimbell R; Aherne GW; Brunton L; Jansen G; Stephens TC; Smith MN; Wardleworth JM; Boyle FT
Clin Cancer Res; 1997 Jun; 3(6):911-21. PubMed ID: 9815766
[TBL] [Abstract][Full Text] [Related]
25. Extracellular glutamine level reduction enhances 5-fluorouracil cytotoxicity.
Sukemori S; Sugimura K
Cancer Biochem Biophys; 1998 Jun; 16(1-2):53-61. PubMed ID: 9923967
[TBL] [Abstract][Full Text] [Related]
26. Toxicity of methotrexate and metoprine in a dihydrofolate reductase gene-amplified mouse cell line.
Hamrell M; Laszlo J; Brown OE; Sedwick WD
Mol Pharmacol; 1981 Nov; 20(3):637-43. PubMed ID: 7329406
[No Abstract] [Full Text] [Related]
27. Isolation of tumor cells from patients with osteosarcoma and analysis of their sensitivity to methotrexate.
Mordoh J; Chacón RD; Filmus J
Cancer Res; 1981 Sep; 41(9 Pt 1):3621-8. PubMed ID: 6942915
[TBL] [Abstract][Full Text] [Related]
28. Comparison of leucovorin protection from variety of antifolates in human lymphoid cell lines.
Browman GP; Spiegl P; Booker L; Rosowsky A
Cancer Chemother Pharmacol; 1985; 15(2):111-4. PubMed ID: 3874720
[TBL] [Abstract][Full Text] [Related]
29. Determinants of activity of the antifolate thymidylate synthase inhibitors Tomudex (ZD1694) and GW1843U89 against mono- and multilayered colon cancer cell lines under folate-restricted conditions.
Peters GJ; Smitskamp-Wilms E; Smid K; Pinedo HM; Jansen G
Cancer Res; 1999 Nov; 59(21):5529-35. PubMed ID: 10554030
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms of resistance to antifolates, a review.
Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR
Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336
[TBL] [Abstract][Full Text] [Related]
31. L-phenylalanine mustard (melphalan) uptake and cross-linking in the RPMI 6410 human lymphoblastoid cell line.
Brox LW; Gowans B; Belch A
Cancer Res; 1980 Apr; 40(4):1169-72. PubMed ID: 7357546
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of DNA synthesis and enhancement of the uptake and action of methotrexate by low-power-density microwave radiation in L1210 leukemia cells.
Chang BK; Huang AT; Joines WT
Cancer Res; 1980 Apr; 40(4):1002-5. PubMed ID: 7357530
[TBL] [Abstract][Full Text] [Related]
33. Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates.
Chung KN; Saikawa Y; Paik TH; Dixon KH; Mulligan T; Cowan KH; Elwood PC
J Clin Invest; 1993 Apr; 91(4):1289-94. PubMed ID: 7682567
[TBL] [Abstract][Full Text] [Related]
34. An enzyme inhibition assay for 2,4-diamino-5-(3'4'-dichlorophenyl)-6-methylpyrimidine (DDMP,NSC 19494).
Calvert AH; Cridland JS; Harrap KR
J Clin Pathol; 1977 Dec; 30(12):1154-7. PubMed ID: 604362
[TBL] [Abstract][Full Text] [Related]
35. The intracellular mechanism of action of metoprine (DDMP).
Browman GP; Calvert AH; Taylor GA; Hart LI; Harrap KR
Eur J Cancer (1965); 1980 Dec; 16(12):1547-54. PubMed ID: 6971755
[No Abstract] [Full Text] [Related]
36. Comparative studies of methotrexate and metoprine: metabolic toxicity and cell killing.
Sedwick WD; Fyfe MJ; Hamrell M; Laszlo J
Adv Enzyme Regul; 1978; 17():399-416. PubMed ID: 294129
[No Abstract] [Full Text] [Related]
37. Sensitivity to 5,10-dideazatetrahydrofolate is fully conserved in a murine leukemia cell line highly resistant to methotrexate due to impaired transport mediated by the reduced folate carrier.
Zhao R; Gao F; Babani S; Goldman ID
Clin Cancer Res; 2000 Aug; 6(8):3304-11. PubMed ID: 10955817
[TBL] [Abstract][Full Text] [Related]
38. A case for the use of aminopterin in treatment of patients with leukemia based on metabolic studies of blasts in vitro.
Smith A; Hum M; Winick NJ; Kamen BA
Clin Cancer Res; 1996 Jan; 2(1):69-73. PubMed ID: 9816092
[TBL] [Abstract][Full Text] [Related]
39. Resistance mechanisms to methotrexate in tumors.
Bertino JR; Göker E; Gorlick R; Li WW; Banerjee D
Stem Cells; 1996 Jan; 14(1):5-9. PubMed ID: 8820944
[TBL] [Abstract][Full Text] [Related]
40. Methotrexate induction of human sulfotransferases in Hep G2 and Caco-2 cells.
Chen X; Baker SM; Chen G
J Appl Toxicol; 2005; 25(5):354-60. PubMed ID: 15986412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
